← ANALYSTS · TIPRANKS
Jeff Jones · Oppenheimer
Hits
46%
114 of 248 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+20.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
13
Buy / hold / sell: 13 / 0 / 0
Upside of the analyst’s targets
+290.3%
Average over 13 current targets, to the last price
The market’s answer to the ratings
−2.6%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 9on TipRanks 06:20 | AKTSIWMAktis Oncology, Inc. · $890M | Initiated | Buy | $40.00 | +165.6% | −3.4%next day +0.1% · 5 days −4.5% | ↗ |
| Sep 8on TipRanks 14:50 | PHVSPharvaris · $2.1B | Reiterated | Buy | $50.00 → $75.00+50.0% | +170.4% | +7.9%next day +0.2% · 5 days +1.7% | ↗ |
| Sep 2on TipRanks 07:45 | ALMSIWMAlumis Inc. · $842M | Reiterated | Buy | $55.00 → $37.00−32.7% | +504.6% | +8.8%next day +8.7% · 5 days −3.4% | ↗ |
| Aug 21on TipRanks 07:50 | AAPGAscentage Pharma Group International Unsponsored ADR · $1.4B | Reiterated | Buy | $45.00 | +192.8% | −2.3%next day −1.4% · 5 days +7.0% | ↗ |
| Aug 14on TipRanks 08:15 | MDWDIWMMediwound · $158M | Reiterated | Buy | $32.00 → $30.00−6.2% | +153.2% | +0.4%next day −0.8% · 5 days −1.2% | ↗ |
| Aug 13on TipRanks 07:50 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $50.00 | +200.1% | −5.3%next day −1.4% · 5 days −0.8% | ↗ |
| Aug 11on TipRanks 07:55 | CATXIWMPerspective Therapeutics · $267M | Reiterated | Buy | $13.00 | +499.1% | +6.3%next day +2.3% · 5 days +1.3% | ↗ |
| Aug 7on TipRanks 10:08 | CRVSIWMCorvus Pharmaceuticals · $789M | Reiterated | Buy | $33.00 | +246.6% | −0.2%next day −1.3% · 5 days +6.6% | ↗ |
| Aug 7on TipRanks 08:20 | CRBPIWMCorbus Pharmaceuticals · $84M | Reiterated | Buy | $52.00 → $48.00−7.7% | +961.9% | +3.8%next day −7.0% · 5 days −1.2% | ↗ |
| Jun 18on TipRanks 08:10 | ODTXIWMOdyssey Therapeutics, Inc. · $844M | Reiterated | Buy | $40.00 | +133.0% | +2.2%next day −1.5% · 5 days −2.9% | ↗ |
| May 8on TipRanks 08:45 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Buy | $10.00 | +204.9% | +0.6%next day +0.2% · 5 days −8.5% | ↗ |
| May 8on TipRanks 08:45 | PHARPharming Group · $670M | Reiterated | Buy | $41.00 → $40.00−2.4% | +327.4% | +7.3%next day −3.0% · 5 days −0.7% | ↗ |
| Feb 27on TipRanks 08:40 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $120 | +14.5% | −3.4%next day −1.4% · 5 days −6.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗